NCT00329095View on ClinicalTrials.gov

An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2005

Study Completion Date

April 30, 2006

Conditions
GlaucomaOcular Hypertension
Interventions
DRUG

travoprost, latanoprost, or bimatoprost

DRUG

Additional ocular hypotensive medication

All Listed Sponsors
lead

Robin, Alan L., M.D.

INDIV

NCT00329095 - An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance | Biotech Hunter | Biotech Hunter